MedTrace Logo

HIP Fracture Accelerated Surgical TreaTment And Care tracK (HIP ATTACK) Trial

NCT02027896 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3001

Last updated 2024-01-22

No results posted yet for this study

Summary

HIP ATTACK is an international randomized controlled trial of 3000 patients with a hip fracture that requires a surgical intervention. This trial will determine the effect of accelerated medical clearance and accelerated surgery compared to standard care on the 90-day risk of mortality and major perioperative complication (i.e., a composite of mortality, nonfatal myocardial infarction, nonfatal pulmonary embolism, nonfatal pneumonia, nonfatal sepsis, nonfatal stroke, and nonfatal life-threatening and major bleeding).

Conditions

  • Hip Fractures

Interventions

OTHER

Accelerated medical clearance and surgery

Rapid medical clearance with targeted arrival to the operating room within 6 hours of diagnosis of a hip fracture requiring surgical repair.

Sponsors & Collaborators

  • Population Health Research Institute

    collaborator OTHER

  • Hamilton Health Sciences Corporation

    collaborator OTHER

  • McMaster University

    lead OTHER

Principal Investigators

  • Philip J Devereaux, MD, PhD · McMaster University

  • Mohit Bhandari, MD, PhD · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-14
Primary Completion
2019-08-24
Completion
2022-09-30

Countries

  • United States
  • Belgium
  • Canada
  • China
  • Colombia
  • France
  • Hong Kong
  • India
  • Italy
  • Malaysia
  • Netherlands
  • Pakistan
  • Poland
  • South Africa
  • Spain
  • Thailand
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02027896 on ClinicalTrials.gov